multiple-sclerosis

Documents about multiple-sclerosis

• Clinical and cost-effectiveness of the iStep-MS physical activity and sedentary behaviour intervention for managing fatigue in people with multiple sclerosis: protocol for a multicentre randomised controlled trial.#392911NCBI PubMed Central
• RETRACTED ARTICLE: Unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis#637642Spiral
• Sex Difference in Oxidative Stress Parameters in Spinal Cord of Rats with Experimental Autoimmune Encephalomyelitis: Relation to Neurological Deficit#643984IBISS
• The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.#871860ClinicalTrials.gov
• Internet Delivered Cognitive Rehabilitation for Mild Cognitive Impairments#888286ClinicalTrials.gov
• Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection#907824ClinicalTrials.gov
• A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.#967505ClinicalTrials.gov
• Are Isokinetic Torque-Angle Models Derived from Healthy Subjects Applicable to Patients with Upper-Limb Neurological Motor Impairment?#11551HAL (France)
• Evaluation of the performance of large language models in responding to medical questions related to multiple sclerosis: A case study of large language models including ChatGPT, Gemini, Grok and Copilot.#174400NCBI PubMed Central
• PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosis#257470HAL (France)
• Association Between Rotarod Tests and Myelin Basic Protein in the Confirmation of the Cuprizone-Induced Rat Multiple Sclerosis Model and the Relationship of These Parameters with Dietary Zinc Status.#368038NCBI PubMed Central
• Treadmill training with rhythmic auditory cueing and/or visual feedback for persons with Multiple Sclerosis: feasibility and effects on gait parameters in a clinical randomized controlled trial#414284bioRxiv / medRxiv
• Motor tract lesion mapping from the brain to the lower spinal cord in people with relapsing–remitting multiple sclerosis: exploring the association between lesion severity and functional consequences by limb#304552HAL (France)
• Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.#332851ClinicalTrials.gov
• Diagnosic and Pronostic Values of Kappa and Lambda Free Light Chains in Central Nervous System Inflammatory Diseases#827722ClinicalTrials.gov
• Exploring the Gut-Brain Axis in Ageing and Neurodegeneration#829789ClinicalTrials.gov
• A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose#840924ClinicalTrials.gov
• Investigation of the Effect of the MIND Diet on Disease Symptoms in Patients With MS#844603ClinicalTrials.gov
• Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)#868009ClinicalTrials.gov
• Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products#905117ClinicalTrials.gov
• Brain Health Registry: An Online Registry to Identify and Assess Subjects for Brain Research#840349ClinicalTrials.gov
• Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects#856205ClinicalTrials.gov
• Nerve Root Block in Spasticity#868336ClinicalTrials.gov
• Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders#948375Repositorio de Universidad Autónoma de Chile.
• Longitudinal changes of serum immunoglobulins under ocrelizumab: factors associated with hypogammaglobulinemia and infection risk in a real-world multiple sclerosis cohort / Amelie Bohn, Fiona S. Teubner, Simone C. Tauber, Anne Waschbisch#675393Deutsche Nationalbibliothek
• Chronic Inflammatory Disease, Lifestyle and Risk of Disease#802181ClinicalTrials.gov
• Neurodegenerative Diseases Progression Markers (MARKERS-NDD)#825305ClinicalTrials.gov
• Non-invasive BCI-controlled Assistive Devices#906080ClinicalTrials.gov
• Tendência temporal da internação e mortalidade por esclerose múltipla na região nordeste, sudeste e centro-oeste do Brasil e seus aspectos nutricionais#336000Repositório da UFES
• Single-cell spatial transcriptomic profiling defines a pathogenic inflammatory niche in chronic active multiple sclerosis lesions#412754Open Access LMU
• Higher dietary nitrate intake is associated with lower likelihood of first clinical diagnosis of central nervous system demyelination in Australian women#824169Research Online
• A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases#878213ClinicalTrials.gov
• An Exploratory Cross-Sectional Study of the Association Between Regular Cigarette Smoking and Level of Disability, Hand Dexterity, Cognitive Impairment, Fatigue, and Markers of Oxidative Stress in Male Patients With Relapsing-Remitting Multiple Sclerosis.#247450NCBI PubMed Central
• Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study#826957ClinicalTrials.gov
• Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases#901188ClinicalTrials.gov
• Cohort Study on Neuroimmune Diseases in the Reproductive Age#806933ClinicalTrials.gov
• Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)#871382ClinicalTrials.gov
• Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological Autoimmune Diseases#903079ClinicalTrials.gov
• Biomarkers in Autoimmune Disease of Nervous System#915215ClinicalTrials.gov
• A multicentre, prospective, randomized, open-label pragmatic trial to compare the effectiveness and safety of interferon beta-1a and glatiramer-acetate in paediatric patients affected by Multiple Sclerosis#625041IRIS
• Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults#861752ClinicalTrials.gov
• Cognition and MRI Markers in MS Patients With Aubagio® Treatment#872049ClinicalTrials.gov
• Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases#883251ClinicalTrials.gov
• The NRC Dataset. Developing a Minimum Dataset for Multidisciplinary Rehabilitation: a Modified E-Delphi Study#852233ClinicalTrials.gov
• Clinician-led, single-blind, randomised controlled trial evaluating the efficacy of a high-intensity resistance and impact training intervention for improving health-related quality of life in people with multiple sclerosis: Protocol for STRONG-MS#233519Research Online
• Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve#846176ClinicalTrials.gov
• Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.#885764ClinicalTrials.gov
• Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma#911315ClinicalTrials.gov
• Sex-specific analysis of early disease course and treatment in a German multiple sclerosis cohort / Philip Lennart Poser, Barbara Gisevius, Marianne Tokic, Anne Lena Fisse, Theodoros Ladopoulos, Achim Berthele, Katrin Giglhuber, Martina Flaskamp, Vinzenz Fleischer, Stefan Bittner, Felix Lüssi, Antonios Bayas, Sven G. Meuth, Christoph Heesen, Corinna Trebst, Brigitte Wildemann, Florian Then Bergh, Gisela Antony, Tania Kümpfel, Joachim Havla, Friedemann Paul, Sandra Nischwitz, Hayrettin Tumani, Uwe Zettl, Bernhard Hemmer, Heinz Wiendl, Frauke Zipp, Nina Timmesfeld, Ralf Gold, Jeremias Motte, Anke Salmen#783934Deutsche Nationalbibliothek
• EPO-0627 Clinical relevance of evoked potentials for disease progression in early multiple sclerosis and clinically isolated syndrome in the ProVal-MS study [Abstract] / Marie Braun, J. Havla, M. Kowarik, H. Tumani, Lars Behrens, Markus Naumann, H. Zimmermann, J. Kirschke, M. Senel, M. Kerschensteiner, Lino Braadt, Verena Steuerwald, Korbinian Holzapfel, Anna Muzalyova, H. Spengler, M. Mühlau, E. Oswald, M. Hagedorn, B. Sailer, B. Bender, I. Vardakas, N. Sollmann, O. Kohlbacher, H. Kestler, F. Kohlmayer, U. Ziemann, F. Albashiti, Frank Kramer, M. Boeker, P. Uibel, S. Buchka, Iñaki Soto-Rey, Sven Olaf Rohr, U. Mansmann, B. Hemmer, Antonios Bayas#661677Deutsche Nationalbibliothek